The H3N2 influenza virus poses a significant concern for this winter due to its potential for increased severity and high transmission rates, especially in vulnerable populations. Historically, H3N2 strains have been associated with more severe illness and a higher risk of complications. New mutations and variation in vaccine uptake may lead to increased numbers of patients in severe respiratory failure, both from primary and secondary infections. Worryingly, we see increased reports of myocarditis and septic cardiomyopathies from influenzae, which bring their unique challenges. Intensive Care Units are starting to feel the strain on capacity, and this is at the beginning of winter.
This webinar, intended for the entire multidisciplinary team, will provide a rapid clinical review of what clinicans need to know to manage patients, keep themselves and staff safe, communicate with families, other professionals and local networks, and implement learnings from the COVID pandemic.
Please ask your questions to the panel pre-event using this link: Panel questions
A recording will be made available to all registered delegates shortly after the webinar.
Speakers
Dr Andrew Conway-Morris
Professor Shondipon Laha
Dr Rajeka Lazarus
